5444492026-04-012026-06-305444492026-06-305444492026-04-012026-06-30in-capmkt:OtherExpenses1Member5444492026-04-012026-06-30in-capmkt:OtherExpenses2Member5444492026-04-012026-06-30in-capmkt:OtherExpenses3Member5444492026-04-012026-06-30in-capmkt:OtherExpenses4Member5444492026-04-012026-06-30in-capmkt:OtherExpenses5Member5444492026-04-012026-06-30in-capmkt:OtherExpenses6Member5444492026-04-012026-06-30in-capmkt:OtherExpenses7Member5444492026-04-012026-06-30in-capmkt:OtherExpenses8Member5444492026-04-012026-06-30in-capmkt:OtherExpenses9Member5444492026-04-012026-06-30in-capmkt:OtherExpenses10Member5444492026-04-012026-06-30in-capmkt:ReportableSegments1Member5444492026-04-012026-06-30in-capmkt:ReportableSegments2Member5444492026-04-012026-06-30in-capmkt:ReportableSegments1Member5444492026-04-012026-06-30in-capmkt:ReportableSegments2Member5444492026-04-012026-06-30in-capmkt:ReportableSegments1Member5444492026-06-30in-capmkt:ReportableSegments1Member5444492026-04-012026-06-30in-capmkt:ReportableSegments2Member5444492026-06-30in-capmkt:ReportableSegments2Member5444492026-04-012026-06-30in-capmkt:ReportableSegments1Member5444492026-06-30in-capmkt:ReportableSegments1Member5444492026-04-012026-06-30in-capmkt:ReportableSegments2Member5444492026-06-30in-capmkt:ReportableSegments2Member5444492026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15444492026-04-012026-06-30ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRxbrli:pureiso4217:INRxbrli:shares544449ANTHEMNOTLISTEDINE0CZ201020Anthem Biosciences LimitedMain BoardEquity2026-04-012027-03-312026-07-212026-07-15INRMillionsQuarterlyFirst quarterMulti segment2026-07-2113:45:002026-07-2115:35:00Not applicable2026-04-012026-06-30UnauditedConsolidated4182180000248890000443107000014856300000-2364000078836000088700002998700004261700002985260000144581000001445810000347050000-1006500002464000000119941000000001199410000920000012086100000000112677000022.132.11002.132.110.01180.28541.6393Interest Value is 8.87 mn as against EBIT of 1454.69 mnPower and fuel155700000R & M - Plant and machinery95830000R & D expenses41890000Pollution control expenses18970000Insurance14470000Printing and stationery11430000Corporate social responsibility expenses9310000Freight and forwarding charges8630000Health and safety expenses8580000Others61360000CRDMO3408020000Speciality Ingredients774160000418218000004182180000CRDMO2322580000Speciality Ingredients3976200002720200000887000012655200001445810000CRDMO0Speciality Ingredients0000CRDMO0Speciality Ingredients0000The assets and liabilities of the Company are often deployed interchangeably across segments, it is impractical to allocate these assets and liabilities to each segment.Hence, assets and liabilities have not been identified to any of the reportable segments. <br /> Remeasurement of Defined benefit Plans946000094600002380000Unrealised Gain on Derivative Assets283000028300007100009200000